Shenzhen Salubris Pharmaceuticals Hits Day Low Amid Price Pressure at CNY 54.68

Shenzhen Salubris Pharmaceuticals Co., Ltd. experienced a notable decline today, with the stock dropping by 4.74% on October 13, 2025. The stock reached an intraday low of CNY 54.68, reflecting a challenging trading session. Over the past week, the stock has seen a more significant decrease of 8.52%, contrasting with the China Shanghai Composite's modest gain of 0.37%.
Despite the recent downturn, Shenzhen Salubris has shown strong performance over the longer term. The company has achieved a remarkable 53.75% increase over the past year, significantly outperforming the China Shanghai Composite, which rose by 18.02%. Year-to-date, the stock has surged by 78.5%, indicating robust growth compared to the broader market.

Financial metrics reveal a return on equity of 7.28% and a price-to-book ratio of 7.15. The company maintains a high dividend yield of 0.91%, which may appeal to certain investors. However, it is important to note that profits have declined by 3.2% over the past year, despite the stock's impressive returns.